Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion type Assertion NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_head.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion wasGeneratedBy ECO_0000203 NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_provenance.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion wasDerivedFrom befree-2016 NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_provenance.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion SIO_000772 20861187 NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_provenance.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion evidence source_evidence_literature NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_provenance.
- NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_assertion description "[The clinical relevance of Brk1 is emphasized by correlative data showing that Von Hippel-Lindau (VHL) patients that also lose the BRK1 gene are protected against the development of tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841138.RA8w8nAgLCK7LA6X-HhN7MuPeg0m7TVqSnnzcfRY6GTbo130_provenance.